Role of aggregated medin in the pathogenesis of thoracic aortic aneurysm and dissection

[1]  L. Tjernberg,et al.  Unwinding fibril formation of medin, the peptide of the most common form of human amyloid. , 2007, Biochemical and biophysical research communications.

[2]  Jeffery A. Jones,et al.  Temporal disparity in the induction of matrix metalloproteinases and tissue inhibitors of metalloproteinases after thoracic aortic aneurysm formation. , 2006, The Journal of thoracic and cardiovascular surgery.

[3]  J. Rosenbloom,et al.  Lactadherin binds to elastin – a starting point for medin amyloid formation? , 2006, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[4]  P. Westermark.  Aspects on human amyloid forms and their fibril polypeptides , 2005, The FEBS journal.

[5]  Hao Jiang,et al.  Aggregation and Porin-like Channel Activity of a β Sheet Peptide , 2005 .

[6]  P. Westermark,et al.  Medin-amyloid: A recently characterized age-associated arterial amyloid form affects mainly arteries in the upper part of the body , 2005, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[7]  Sebastian Amigorena,et al.  Lactadherin promotes VEGF-dependent neovascularization , 2005, Nature Medicine.

[8]  S. Takamoto,et al.  Altered patterns of gene expression specific to thoracic aortic aneurysms: microarray analysis of surgically resected specimens. , 2005, International heart journal.

[9]  J. Elefteriades,et al.  Increased tissue microarray matrix metalloproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. , 2004, The Annals of thoracic surgery.

[10]  H. Safi,et al.  Aortic dissection , 2004, The British journal of surgery.

[11]  P. Lansbury,et al.  Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. , 2003, Annual review of neuroscience.

[12]  D. Holtzman,et al.  Matrix metalloproteinase–9 and spontaneous hemorrhage in an animal model of cerebral amyloid angiopathy , 2003, Annals of neurology.

[13]  G. Plant,et al.  Cerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View , 2003, Journal of neuropathology and experimental neurology.

[14]  Giampaolo Merlini,et al.  Molecular mechanisms of amyloidosis. , 2003, The New England journal of medicine.

[15]  W. V. Van Nostrand,et al.  Pathogenic Aβ induces the expression and activation of matrix metalloproteinase‐2 in human cerebrovascular smooth muscle cells , 2003 .

[16]  P. Gottschall,et al.  β-Amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes , 2003, Brain Research.

[17]  Carl W. Cotman,et al.  Common Structure of Soluble Amyloid Oligomers Implies Common Mechanism of Pathogenesis , 2003, Science.

[18]  G. E. Gilbert,et al.  Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites. , 2003, Blood.

[19]  F. Lemonnier,et al.  Characterization of novel breast carcinoma-associated BA46-derived peptides in HLA-A2.1/D(b)-beta2m transgenic mice. , 2002, The Journal of clinical investigation.

[20]  Keiko Miwa,et al.  Identification of a factor that links apoptotic cells to phagocytes , 2002, Nature.

[21]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[22]  P. Westermark,et al.  Medin and medin‐amyloid in ageing inflamed and non‐inflamed temporal arteries , 2002, The Journal of pathology.

[23]  M. Sousa,et al.  Familial Amyloid Polyneuropathy: Receptor for Advanced Glycation End Products-Dependent Triggering of Neuronal Inflammatory and Apoptotic Pathways , 2001, The Journal of Neuroscience.

[24]  D. Spina,et al.  Smooth muscle cells of the media in the dilatative pathology of ascending thoracic aorta: morphology, immunoreactivity for osteopontin, matrix metalloproteinases, and their inhibitors. , 2001, Human pathology.

[25]  M. Moskowitz,et al.  Structural and functional disruption of vascular smooth muscle cells in a transgenic mouse model of amyloid angiopathy. , 2001, The American journal of pathology.

[26]  M. Staufenbiel,et al.  Spontaneous Hemorrhagic Stroke in a Mouse Model of Cerebral Amyloid Angiopathy , 2001, The Journal of Neuroscience.

[27]  I. Wilson,et al.  Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. , 2000, European journal of biochemistry.

[28]  S. Horiuchi,et al.  Advanced glycation end product in familial amyloidotic polyneuropathy (FAP) , 2000, Journal of internal medicine.

[29]  L. Tjernberg,et al.  Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Kiwan,et al.  Protective function of human milk: the milk fat globule. , 1999, Seminars in perinatology.

[31]  M. Giuffrida,et al.  Multiple forms of lactadherin (breast antigen BA46) and butyrophilin are secreted into human milk as major components of milk fat globule membrane , 1999, Journal of Dairy Research.

[32]  G. Holmgren,et al.  Oxidative stress is found in amyloid deposits in systemic amyloidosis. , 1997, Biochemical and biophysical research communications.

[33]  C. Behl,et al.  Amyloid peptides are toxic via a common oxidative mechanism. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[34]  P. Westermark,et al.  Mechanisms of transthyretin amyloidogenesis. Antigenic mapping of transthyretin purified from plasma and amyloid fibrils and within in situ tissue localizations. , 1994, The American journal of pathology.

[35]  R. Bucala,et al.  Advanced glycation end products contribute to amyloidosis in Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  P. Westermark,et al.  Senile aortic amyloid. Evidence for two distinct forms of localized deposits. , 1992, The American journal of pathology.

[37]  I. Lieberburg,et al.  Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. , 1990, Science.

[38]  H. Schägger,et al.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.

[39]  R A Kyle,et al.  Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. , 1983, The American journal of medicine.

[40]  D. Cooley,et al.  The morphology of ascending aortic aneurysms. , 1983, Human pathology.

[41]  R. Ceriani,et al.  Circulating human mammary epithelial antigens in breast cancer. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Uchino,et al.  PATHOLOGICAL STUDY ON AMYLOIDOSIS —RELATIONSHIP OF AMYLOID DEPOSITS IN THE AORTA TO AGING— , 1978, Acta pathologica japonica.

[43]  H. Puchtler,et al.  ON THE BINDING OF CONGO RED BY AMYLOID , 1962 .

[44]  Hao Jiang,et al.  Aggregation and porin-like channel activity of a beta sheet peptide. , 2005, Biochemistry.

[45]  P. Gottschall,et al.  Beta-amyloid induces the production of active, matrix-degrading proteases in cultured rat astrocytes. , 2003, Brain research.

[46]  W. V. Van Nostrand,et al.  Pathogenic A beta induces the expression and activation of matrix metalloproteinase-2 in human cerebrovascular smooth muscle cells. , 2003, Journal of neurochemistry.

[47]  Kenneth H. Johnson,et al.  Staining methods for identification of amyloid in tissue. , 1999, Methods in enzymology.

[48]  C. Behl,et al.  Hydrogen peroxide mediates amyloid beta protein toxicity. , 1994, Cell.